期刊文献+

脑卒中的代谢组学研究进展 被引量:1

Research Progress of Metabonomics in Stroke
下载PDF
导出
摘要 目的分析脑卒中的代谢组学研究现状。方法收集国内外文献,分析脑卒中(缺血性、出血性)及中药治疗脑卒中后的代谢组学变化。结果与结论代谢组学从糖代谢、氨基酸代谢、脂代谢、叶酸循环代谢等途径研究脑卒中后的代谢变化,发现新的生物标志物和代谢物通路,有助于进一步阐明中医药治疗脑卒中的的作用机制和确切靶点,丰富中医药内涵。目前的研究以缺血性脑卒中为主,出血性脑卒中的相关研究较缺乏;且主要集中于筛选差异性代谢物,未对差异性代谢物的特异性和敏感性进行深入研究。需进一步验证代谢物相关通路,开展中医药防治脑出血相关代谢组学研究。 Objective To analyze the research status of metabonomics in stroke.Methods The literature at home and abroad was searched to analyze the stroke(ischemic and hemorrhagic stroke)and metabonomic changes of stroke treated with traditional Chinese medicine(TCM).Results and Conclusion The research of metabolic changes after stroke is carried out from the aspects of glucose metabolism,amino acid metabolism,lipid metabolism and folate cycle metabolism of metabolomics to find new biomarkers and metabolite pathways,which is helpful to further clarify the action mechanism and exact target of TCM in the treatment of stroke and enrich the connotation of TCM.The current researches are mainly ischernic stroke,and there is a lack of related research on hemorrhagic stroke.The researches mainly focus on screening differential metabolites,and there is no in-depth research on the specificity and sensitivity of differential metabolites.It is necessary to further verify metabolite-related pathways and carry out metabolomics research related to the prevention and treatment of intracerebral hemorrhage with TCM.
作者 谭群 熊昕 TAN Qun;XIONG Xin(Department of Encephalopathy,Chongqing Hospital of Traditional Chinese Medicine,Chongqing,China 400011)
出处 《中国药业》 CAS 2022年第10期128-128,I0001,I0002,I0003,共4页 China Pharmaceuticals
基金 国家中医药管理局中医药循证能力建设项目[2019XZZX-NB014] 重庆市科研机构绩效激励引导专项[jxyn2019-2-1]。
关键词 脑卒中 代谢组学 生物标志物 代谢途径 研究进展 stroke metabolomics biomarkers metabolic pathway research progress
  • 相关文献

参考文献11

二级参考文献79

共引文献215

同被引文献22

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部